Finasteride can make a prostate cancer screening result look normal when it is not.
Not by causing anything. By changing a number. That screening test measures a protein called PSA, and finasteride roughly halves the reading.[1][2]
The fix takes one sentence. Tell whoever orders the test that you are taking it, and they will read the result differently.
Almost nobody hears this before they start finasteride 1mg for hair, and it is not the only thing missing from that conversation.
What It Actually Does
Pattern thinning is driven by DHT, a hormone your body converts from testosterone using an enzyme called 5-alpha-reductase. In genetically susceptible follicles, DHT shortens the growth phase with every cycle until the hair produced is too fine to give coverage.
Finasteride inhibits that enzyme. Less conversion, less DHT, less pressure on the follicle.
This makes it different in kind from minoxidil, which extends the growth phase without touching the hormone. Minoxidil improves what you have. Finasteride acts on the process that is taking it away. That is why the two are usually combined rather than compared.
Finasteride 1mg for Hair: What the Numbers Show
The trial that established it enrolled 1,553 men aged 18 to 41 on 1 mg daily or placebo, with 1,215 continuing into a blinded second year.[3]
Measured in a one-inch circle of scalp holding roughly 876 hairs at baseline, the finasteride group ended with 107 more hairs than placebo at one year and 138 more at two years.[3]
Two things are worth drawing out of that.
The gap widened between year one and year two, which tells you this is not a drug you assess in a single season. And it is measured against placebo rather than against the starting point, which matters because the placebo group was still losing ground.
A meaningful part of the benefit is not regrowth. It is loss that did not happen.
The Side Effects, Stated Honestly
This is where most articles either minimise or catastrophise, so here is the actual shape of the evidence.
In a multicentre study of 424 men, drug-related sexual dysfunction was reported by 8.7% on finasteride against 5.1% on placebo.[4] That is a real difference and a smaller one than the internet suggests, and note that one in twenty men reported the same problems on a sugar pill.
Reported effects include reduced libido, difficulty with erections, changes in ejaculation, breast tenderness and mood changes.
On resolution, one major trial found sexual adverse effects resolved in all patients after stopping the drug, and also resolved in most men who stayed on it.[4]
The Part About Persistence
You will find claims online that these effects can persist indefinitely after stopping. The honest position is that this is contested rather than settled.
The studies reporting high rates of persistence, one finding 89% of subjects still affected at follow-up, have substantial selection bias, recall bias and no proper controls.[4] They recruited from populations already reporting harm.
Against that, the Prostate Cancer Prevention Trial followed 17,313 men, and none reported persistent sexual dysfunction.[4]
That does not prove the phenomenon does not exist. It means the evidence available cannot currently tell you how common it is, and anyone claiming certainty in either direction is going beyond what has been shown.
What that argues for is a proper conversation with a doctor rather than a decision made from a forum thread or from a product page.
Who Must Not Take It
Women who are pregnant, may become pregnant, or are breastfeeding must not take or even handle these tablets. Finasteride can affect the development of a male foetus. This is not a precaution to be weighed against benefits. It is absolute.
Broken or crushed tablets are the specific risk, which is why handling matters and not only swallowing.
It is intended for adult men, and in India it is a prescription medicine.
What It Cannot Do
It does not rebuild bare scalp. If the front of your head is smooth rather than wispy, no drug creates a follicle that has already gone.
It does not work while you are not taking it. Stop, and the follicles resume their earlier course over the following months, taking the gains with them.
It does not work quickly. Three to six months before any assessment, and the two-year data suggests the honest read comes later still.
It is also not the answer for women. Finasteride is not first-line for female pattern thinning, and the pregnancy restriction rules it out entirely for a large share of the women who might otherwise consider it.
Making the Decision
The awkward truth is that avoiding the decision is itself a decision, and it has a cost measured in follicles.
Every month a follicle spends miniaturising is ground that gets harder to recover. Men who read forums for two years before starting have not avoided a risk. They have traded a manageable, reversible, discussable side-effect risk for a certain and irreversible loss of density.
That is not an argument for taking it. It is an argument for making the finasteride 1mg for hair decision deliberately, with someone qualified, rather than by default.
Which is also why the dispensing route matters. Products such as URoots route finasteride through a clinic doctor's review before it is supplied, which is what a prescription medicine should require. Anywhere selling it without that step is worth avoiding, whatever it costs.
Before you start, take a photograph of your scalp in fixed light and note the date. Twelve months from now that photograph is the only thing that will tell you honestly whether it worked, and by then you will not remember what you looked like.
Ask your doctor three things: what you should expect at month six, what to do if side effects appear, and to note in your record that you are taking it, so that any future PSA result gets read correctly.
References
D'Amico AV, Roehrborn CG. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Lancet Oncol. 2007;8(1):21-5.
Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses. Nat Clin Pract Urol. 2007.
Kaufman KD, Olsen EA, Whiting D, Fiedler V, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-89.
Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring? J Clin Aesthet Dermatol.